These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 12930144

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Familiar O, Munier-Lehmann H, Negri A, Gago F, Douguet D, Rigouts L, Hernández AI, Camarasa MJ, Pérez-Pérez MJ.
    ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
    [Abstract] [Full Text] [Related]

  • 3. Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Vanheusden V, Munier-Lehmann H, Froeyen M, Busson R, Rozenski J, Herdewijn P, Van Calenbergh S.
    J Med Chem; 2004 Dec 02; 47(25):6187-94. PubMed ID: 15566289
    [Abstract] [Full Text] [Related]

  • 4. Rational design of 5'-thiourea-substituted alpha-thymidine analogues as thymidine monophosphate kinase inhibitors capable of inhibiting mycobacterial growth.
    Van Daele I, Munier-Lehmann H, Froeyen M, Balzarini J, Van Calenbergh S.
    J Med Chem; 2007 Nov 01; 50(22):5281-92. PubMed ID: 17910427
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans.
    Pochet S, Dugué L, Labesse G, Delepierre M, Munier-Lehmann H.
    Chembiochem; 2003 Aug 04; 4(8):742-7. PubMed ID: 12898625
    [Abstract] [Full Text] [Related]

  • 10. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
    Gasse C, Douguet D, Huteau V, Marchal G, Munier-Lehmann H, Pochet S.
    Bioorg Med Chem; 2008 Jun 01; 16(11):6075-85. PubMed ID: 18467107
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Gasse C, Huteau V, Douguet D, Munier-Lehmann H, Pochet S.
    Nucleosides Nucleotides Nucleic Acids; 2007 Jun 01; 26(8-9):1057-61. PubMed ID: 18058536
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Novel nucleotide analogues as potential substrates for TMPK, a key enzyme in the metabolism of AZT.
    Müller HC, Meier C, Balzarini J, Reinstein J.
    Nucleosides Nucleotides Nucleic Acids; 2003 Jun 01; 22(5-8):821-3. PubMed ID: 14565287
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and evaluation of 5'-modified thymidines and 5-hydroxymethyl-2'-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors.
    Toti KS, Verbeke F, Risseeuw MD, Frecer V, Munier-Lehmann H, Van Calenbergh S.
    Bioorg Med Chem; 2013 Jan 01; 21(1):257-68. PubMed ID: 23199481
    [Abstract] [Full Text] [Related]

  • 18. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
    Kumar A, Chaturvedi V, Bhatnagar S, Sinha S, Siddiqi MI.
    J Chem Inf Model; 2009 Jan 01; 49(1):35-42. PubMed ID: 19063713
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.